ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACRX AcelRX Pharmaceuticals Inc

0.86
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
AcelRX Pharmaceuticals Inc ACRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.86 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.86 0.86
more quote information »

Recent News

Date Time Source Heading
3/21/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/15/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/12/202418:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/09/202409:17EDGAR2Form 8-K - Current report
1/09/202409:05PRNUSAcelRx Announces Rebranding With Name Change to Talphera,..
12/14/202308:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202316:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/13/202316:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:30PRNUSAcelRx Pharmaceuticals Announces Publication of Study..
12/01/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
11/22/202316:38EDGAR2Form S-3 - Registration statement under Securities Act of..
11/22/202316:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/14/202306:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:14EDGAR2Form 8-K - Current report
11/08/202316:05PRNUSAcelRx Reports Third Quarter 2023 Financial Results and..
11/07/202316:05PRNUSAcelRx to Host KOL Panel Discussion on Current Anticoagulant..
10/26/202316:30PRNUSAcelRx to Host Third Quarter 2023 Financial Results Call and..
10/20/202316:30EDGAR2Form 8-K - Current report
10/10/202316:17EDGAR2Form 8-K - Current report
10/05/202316:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/05/202316:30EDGAR2Form 8-K - Current report
10/03/202308:30PRNUSAcelRx Receives IDE Approval for Niyad and Advances to a..
9/22/202317:18EDGAR2Form 8-K - Current report
9/11/202319:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/06/202308:30PRNUSAcelRx Pharmaceuticals to Participate in the H.C. Wainwright..
8/28/202306:35EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
8/28/202306:34EDGAR2Form DEF 14A - Other definitive proxy statements
8/25/202316:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/25/202312:45EDGAR2Form 144 - Report of proposed sale of securities
8/24/202316:23EDGAR2Form 144 - Report of proposed sale of securities
8/10/202317:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202316:10EDGAR2Form 8-K - Current report
8/10/202316:05PRNUSAcelRx Reports Second Quarter 2023 Financial Results and..
8/09/202317:29EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
8/02/202306:06EDGAR2Form S-3 - Registration statement under Securities Act of..
7/27/202316:05PRNUSAcelRx to Host Second Quarter 2023 Financial Results Call..
7/21/202308:15EDGAR2Form 8-K - Current report
7/21/202308:00PRNUSAcelRx Pharmaceuticals Announces Closing of Previously..
7/18/202308:00PRNUSAcelRx Pharmaceuticals Announces $10 Million Private..
5/10/202316:05PRNUSAcelRx Pharmaceuticals Reports First Quarter 2023 Financial..
4/27/202316:05PRNUSAcelRx to Host First Quarter 2023 Financial Results Call and..
4/05/202308:30PRNUSAcelRx Pharmaceuticals Announces Closing of Divestment of..
3/30/202316:05PRNUSAcelRx Pharmaceuticals Reports Full Year and Fourth Quarter..

Your Recent History

Delayed Upgrade Clock